Medik8 Raises $1.1 Billion

Medik8, the British dermatological skincare brand, has successfully raised $1.1 billion in new investment capital from a consortium of investors. This significant funding round will support the company's strategic growth objectives and further solidify its position in the global skincare market. Founded in 2009 by UK scientists, Medik8 has established itself as a globally renowned brand known for its age-defying skincare solutions that prioritize efficacy without compromise. The company pioneered the simple yet effective CSA Philosophy, advocating for vitamin C and sunscreen during the day, followed by vitamin A at night, as a core regimen for achieving youthful skin. Every Medik8 product is developed to deliver results-driven, scientific skincare, suitable for all skin types, and is backed by independent clinical studies and rigorous testing, earning recommendations from experts and dermatologists worldwide. The substantial capital injection underscores investor confidence in Medik8's unique approach to dermatological skincare and its robust business model. Medik8 manufactures virtually all its products in-house at its ISO-certified Innovation Centre just outside London, ensuring consistent UK standards of excellence through high-quality ingredients and patented technologies. As one of only 66 beauty manufacturers globally to achieve B Corp™ certification, the company also demonstrates a strong commitment to sustainability, focusing on reducing carbon and plastic waste and prioritizing renewable energy. Medik8 plans to strategically deploy these funds to accelerate product innovation, expand its international market presence, and enhance its operational capabilities. This investment is poised to fuel the company's continued trajectory, enabling it to further its mission of simplifying the route to great skin through trusted, high-performance science, while upholding its core values of integrity, community, expertise, and innovation. The company anticipates a period of accelerated growth as it continues to bring its advanced skincare solutions to a broader global audience.